K.C. Pharmaceuticals, Inc. Warning Letter Details
Warning LetterK.C. Pharmaceuticals, Inc.
Issue DateAugust 12, 2026
FEI NumberN/A
Violations3
CountryN/A
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
OpenSubject
CGMP/Finished Pharmaceuticals/Adulterated